Articles selected in February 2004
暂无分享,去创建一个
[1] J. Hartman,et al. Estrogen receptor β inhibits 17β-estradiol-stimulated proliferation of the breast cancer cell line T47D , 2004 .
[2] L. Holmberg,et al. HABITS (hormonal replacement therapy after breast cancer—is it safe?), a randomised comparison: trial stopped , 2004, The Lancet.
[3] Martin R. Schneider,et al. Characterization of new estrogen receptor destabilizing compounds: effects on estrogen-sensitive and tamoxifen-resistant breast cancer. , 2004, Journal of the National Cancer Institute.
[4] A. Wellstein,et al. Impact of the nuclear receptor coactivator AIB1 isoform AIB1-Δ3 on estrogenic ligands with different intrinsic activity , 2004, Oncogene.
[5] C. J. Barnes,et al. p21-activated Kinase-1 Signaling Mediates Cyclin D1 Expression in Mammary Epithelial and Cancer Cells* , 2004, Journal of Biological Chemistry.
[6] R. Nicholson,et al. Nonendocrine Pathways and Endocrine Resistance , 2004, Clinical Cancer Research.
[7] Rakesh Kumar,et al. Adaptive Hypersensitivity to Estrogen , 2004, Clinical Cancer Research.
[8] E. Appella,et al. Suppression of breast cancer by chemical modulation of vulnerable zinc fingers in estrogen receptor , 2004, Nature Medicine.
[9] J. Hartman,et al. Estrogen receptor beta inhibits 17beta-estradiol-stimulated proliferation of the breast cancer cell line T47D. , 2004, Proceedings of the National Academy of Sciences of the United States of America.